A Study of Ramucirumab (LY3009806) in Participants With Advanced Liver Cancer

Clinical trial NCT02069041 · COMPLETED

Trial details

NCT number: NCT02069041
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Carcinoma, Hepatocellular

Start date: 2014-04-01
Primary completion: 2016-09-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.